1-8 of 8
Jan Jacob Schuringa
Close
Sort by
Journal Articles

The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia

Alan Cunningham, Lieve L. Oudejans, Marjan Geugien, Diego Antonio Pereira-Martins, Albertus T. J. Wierenga, Ayşegül Erdem, Dominique Sternadt, Gerwin Huls, Jan Jacob Schuringa
Journal: Blood Advances
Blood Adv (2023) 8 (1): 56–69.
https://doi.org/10.1182/bloodadvances.2023010786
Published: 2023
Includes: Supplemental data
Journal Articles

Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control study

Carin L. E. Hazenberg, Aniek O. de Graaf, René Mulder, Laura B. Bungener, Maaike G. J. M. van Bergen, André B. Mulder, Goda Choi, Jan Jacob Schuringa, Marco R. de Groot, Edo Vellenga, Joop H. Jansen, Gerwin Huls, Isabelle A. van Zeventer
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1269–1278.
https://doi.org/10.1182/bloodadvances.2022007497
Published: 2023
Includes: Supplemental data
Journal Articles

Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals

Isabelle A. van Zeventer, Aniek O. de Graaf, Theresia N. Koorenhof-Scheele, Bert A. van der Reijden, Melanie M. van der Klauw, Avinash G. Dinmohamed, Arjan Diepstra, Jan Jacob Schuringa, Luca Malcovati, Gerwin Huls, Joop H. Jansen
Journal: Blood Advances
Blood Adv (2022) 6 (14): 4174–4184.
https://doi.org/10.1182/bloodadvances.2021006755
Published: 2022
Includes: Supplemental data
Journal Articles

CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clones

Roos Houtsma, Nisha K. van der Meer, Kees Meijer, Linde M. Morsink, Shanna M. Hogeling, Carolien M. Woolthuis, Emanuele Ammatuna, Marije T. Nijk, Bauke de Boer, Gerwin Huls, André B. Mulder, Jan Jacob Schuringa
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2129–2143.
https://doi.org/10.1182/bloodadvances.2021005018
Published: 2022
Includes: Supplemental data
Journal Articles

Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality

Clinical Trials & Observations
Isabelle A. van Zeventer, Aniek O. de Graaf, Melanie M. van der Klauw, Edo Vellenga, Bert A. van der Reijden, Jan Jacob Schuringa, Arjan Diepstra, Luca Malcovati, Joop H. Jansen, Gerwin Huls
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3266–3278.
https://doi.org/10.1182/bloodadvances.2021004355
Published: 2021
Includes: Supplemental data
Journal Articles

Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years

Clinical Trials & Observations
Isabelle A. van Zeventer, Jonas B. Salzbrunn, Aniek O. de Graaf, Bert A. van der Reijden, H. Marike Boezen, Judith M. Vonk, Pim van der Harst, Jan Jacob Schuringa, Joop H. Jansen, Gerwin Huls
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2115–2122.
https://doi.org/10.1182/bloodadvances.2020004062
Published: 2021
Includes: Supplemental data
Journal Articles

Erythrocytosis in the general population: clinical characteristics and association with clonal hematopoiesis

Clinical Trials & Observations
Hanneke J. C. M. Wouters, René Mulder, Isabelle A. van Zeventer, Jan Jacob Schuringa, Melanie M. van der Klauw, Pim van der Harst, Arjan Diepstra, André B. Mulder, Gerwin Huls
Journal: Blood Advances
Blood Adv (2020) 4 (24): 6353–6363.
https://doi.org/10.1182/bloodadvances.2020003323
Published: 2020
Includes: Supplemental data
Journal Articles

RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs

Mylène Gerritsen, Guoqiang Yi, Esther Tijchon, Jorren Kuster, Jan Jacob Schuringa, Joost H. A. Martens, Edo Vellenga
Journal: Blood Advances
Blood Adv (2019) 3 (3): 320–332.
https://doi.org/10.1182/bloodadvances.2018024422
Published: 2019
Includes: Supplemental data